Dermatology Advisor47m
Top FDA Vaccine Official Quits, Warns of Vaccine Misinformation
Dr Peter Marks is resigning as director of the FDA's Center for Biologics Evaluation and Research by April 5 due to objections to RFK Jr.
HealthDay on MSN1h
FDA Delays Final Approval of Novavax COVID Vaccine
Key Takeaways The U.S. Food and Drug Administration has delayed full approval of Novavax's COVID vaccineThe agency says it needs more data before making a final decisionNovavax says its vaccine is ...
'Decapitated': More top vaccine regulators out at FDA, threatening new approvals
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Managed Healthcare Executive3h
New Trial to Investigate Osteoporosis Drug for Type 1 Diabetes
The study explores whether Prolia/Xgeva (denosumab), a widely used therapy for osteoporosis and bone tumors, can regenerate ...
The American Journal of Managed Care3h
American Advocacy and Action for Minority Health in 2025
Accessing equitable health care is an ongoing struggle in the US for minority communities due to historical pretexts with new ...
Medscape4h
Many With Hidradenitis Suppurativa Unaware of FDA-Approved Treatments: Survey
A national survey reveals that most individuals with hidradenitis suppurativa are unaware of US Food and Drug ...
KOSU4h
Oklahoma's DOGE report proposes major cuts to federal health services
A new report by Oklahoma’s Division of Government Efficiency lays out several major policy shifts for the state. Ideas ...
North Carolina Health News6h
Legislative battle continues over how to address health care costs in North Carolina
The N.C. Senate and House of Representatives differ on how to make health care more affordable and accessible, including prior authorization.
Judge foils FDA plan to regulate lab-developed tests
The FDA finalized a rule to oversee lab-developed tests as if they were medical devices, prompting lawsuits. Opponents said ...
FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance
The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
Novavax bid for full approval of COVID vaccine stymied by FDA - report
The FDA delays full approval for Novavax's COVID-19 vaccine, citing the need for additional data. Read more here.
US Supreme Court largely backs FDA's denial of flavored vape product applications
The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette ...